Objective: The optimal timing of carotid revascularization in symptomatic patients is widely debated. Therefore, we compared outcomes of revascularization <1 month vs 1 month after the index stroke.
Methods: We selected patients with preprocedural strokes undergoing nonemergent carotid endarterectomy (CEA) and carotid stenting (CAS) in the Vascular Quality Initiative between 2012 and 2017. We evaluated the risk of in-hospital stroke and 30-day mortality for expedited (<1 month) vs delayed (1 month) revascularization using multilevel logistic regression.
Results: Of 12,520 patients with an index stroke, 10,127 (81%) underwent CEA and 2393 (19%) underwent CAS. Of CEA patients, 56% (n ¼ 5668) underwent expedited revascularization compared with 59% (n ¼ 1402) for CAS (P ¼ .02). After adjustment, expedited revascularization in CEA patients was associated with a higher odds of stroke compared with delayed revascularization (odds ratio [OR] , 1.6 [95% confidence interval, 1.2-2.1]; P ¼ .002; Fig) but not mortality (OR, 1.4 [0.9-2.2]; P ¼ .1). Among CAS patients, expedited revascularization was not associated with stroke (OR, 1.3 [0.9-2.1]; P ¼ .2). However, expedited CAS was associated with dramatically higher mortality compared with delayed revascularization (OR, .5]; P < .001). Among patients with expedited revascularization, CAS patients experienced a similar stroke risk to that of CEA patients (OR,1.4 [0.9-2.2]; P ¼ .1) but a higher mortality risk (OR, 2.2 [1.4-3.5]; P ¼ .001), whereas among those undergoing delayed revascularization, CAS was associated with stroke (OR, 2.6 [1.5-4.4]; P < .001) but not with mortality (OR, 0.2 [0.03-1.6]; P ¼ .1). In addition, patients with a major index stroke experienced a stroke/death rate of 11% after expedited CAS vs 5.7% after expedited CEA (P ¼ .005).
Conclusions: Symptomatic patients undergoing expedited CEA or CAS after their index stroke experienced a higher procedural risk than those undergoing delayed revascularization. However, CAS was associated with higher procedural risk than CEA, especially among those undergoing revascularization <1 month of the index stroke. Objective: The German National Quality Assurance Registry includes the data sets of all procedures (carotid endarterectomy [CEA] and carotid artery stenting [CAS] ) performed in German hospitals. The in-hospital outcome is reported by a questionnaire and finally evaluated and monitored by a federal institution (IQTIG) with the assistance of a clinical advisory board. It was the aim of this presentation to report the outcome of CEA vs CAS.
Methods: Data were collected at discharge on a mandatory electronic basis and primarily transferred to local state agencies (n ¼ 11) for plausibility check and monitoring. The data sets were anonymously compiled and evaluated by a federal institute (IQTIG). The quality of the registry is checked on a yearly basis by random sample analysis of individual charts. The reports from 2014 to 2016 include the data sets from 96,990 patients. There were 78,436 CEA (79.0%) and 18,554 CAS (18.7%) procedures performed; 2.2% of the CEA and 8.1% of the CAS procedures were special indications, including interventions before intracranial interventional procedures or other indications. Emergency procedures were included in the registry (7.0% CEA, 13.8% CAS).
Results: There were 664 hospitals that performed CEA or CAS in 2016 (654 in 2014). In 2016, 294 hospitals performed <20 CEAs (285 CASs) in asymptomatic patients and 358 hospitals in symptomatic cases (258 CASs), respectively. The rates of preoperative neurologic examination improved to 70.9% in 2016 for CEA (68.0% in 2014) and 83.1% for CAS (77.6% in 2014). The postoperative rates were 61.2% for CEA and 61.2% for CAS in 2016 and 57.2% for CEA and 70.1% for CAS in 2014. The results for stroke and death for asymptomatic carotid stenosis were 1.18% (2016) and 1.12% (2014) for CEA and 1.71% and 1.76%, respectively, for CAS. In the case of contralateral stenosis, the results were 1.91% and 2.64% for CEA and 1.82% and 1.4% for CAS. In symptomatic stenosis, stroke/death rates for CEA were 2.87% (2016) and 2.35% (2014). CAS resulted in stroke/death rates of 3.87% and 3.5%.
Conclusions: This is the largest available registry on extracranial carotid procedures in Europe. The relative percentage of CAS procedures has been rising (18.3% to 20.0%) in the last 3 years. Both methods resulted in acceptable results for treatment of asymptomatic stenosis on a national scale. CAS was more often used in acute stroke and in combination Objective: Elevated blood pressure is associated with primary manifestations of cerebrovascular disease, such as stroke and myocardial infarction. Moreover, untreated hypertension contributes to atherosclerotic disease progression and is a risk factor for periprocedural complications in patients undergoing carotid endarterectomy (CEA). It is currently unknown how hypertension influences this underlying culprit of cerebrovascular disease, namely, the atherosclerotic plaque. Therefore, the aim of this study was to determine whether blood pressure influences vulnerable plaque characteristics in patients undergoing CEA.
Methods: There were 1693 patients undergoing CEA between 2002 and 2014 at two large Dutch tertiary referral centers who were included from an ongoing prospective biobank study. Atherosclerotic plaques were excised in toto and analyzed for the presence of calcifications, collagen, smooth muscle cells, macrophages, lipid core, intraplaque hemorrhage (IPH), and vessel density. Blood pressure was measured within 72 hours before surgery. Associations between blood pressure (systolic and diastolic), patients' characteristics, and histologic characteristics of the atherosclerotic plaque of the carotid artery were assessed with univariate and multivariate analyses with correction for potential confounders.
Results: Univariate logistic regression analyses showed that histologic vulnerable plaque characteristics such as calcifications (P ¼ .008), macrophages (P ¼ .007), lipid core (P ¼ .008), IPH (P ¼ .015), and microvessels (P ¼ .009) were associated with increase of systolic blood pressure. After adjustment of possible confounders, such as age, sex, diabetes mellitus, kidney function measured by estimated glomerular filtration rate, history of coronary artery disease, and statin use, multivariate analyses showed that these histologic vulnerable plaque characteristics yielded the strongest association for systolic blood pressure. Moreover, histologic vulnerable plaque characteristics like the number of macrophages (P < .001), lipid core (P ¼ .012), and IPH (P ¼ .012) were significantly associated with increase of diastolic blood pressure. After adjustment of potential confounders, these vulnerable plaque characteristics retained a strong association with high diastolic blood pressure. Calcifications and microvessels were not associated with diastolic blood pressure.
Conclusions: Increased systolic and diastolic blood pressure are both strong determinants for the presence of increased vulnerability of atherosclerotic lesions in patients treated for carotid artery stenosis.
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The "Bare Branch" as an Adjunct to Prevent Paraplegia After Total Endovascular Repair of Thoracoabdominal Aneurysms Objective: Staged endovascular treatment of thoracoabdominal aortic aneurysms (TAAAs) with the temporary perfusion of the sac through a branch left unstented or a dedicated branch is an effective strategy to reduce the risk of postoperative spinal cord ischemia (SCI). However, some drawbacks, such as aneurysmal sac progression in the period between stages and the risk of visceral embolism and component displacement, have been highlighted. We here present the bare branch approach, a safe adjunct to TAAA repair in terms of interstage complications.
Methods: In the first step, one branch, preferentially the one for the connecting tube, is stented by a bare stent; in a second step, a covered stent is released inside the bare branch (Fig 1) . At our center from January 2015 to December 2016 (mean follow-up, 13 months), 22 TAAAs (5 type I, 6 type II, 8 type III, 3 type IV) were treated by this approach. Data were prospectively collected and retrospectively analyzed. Primary end points were technical success, survival, freedom from aneurysm growth between the two stages, freedom from SCI, and aneurysm exclusion after the second stage.
Results: Preoperative mean maximum diameter was 68.4 mm; 19 Cook endografts (5 t-Branch, 14 custom; Cook Medical, Bloomington, Ind) and 3 Jotec custom-made endografts (Jotec, Hechingen, Germany) were used. The mean total aortic coverage was 402 mm (210-570 mm). The mean interval time between the two stages was 7.5 weeks (6-12 weeks). In-hospital mortality was 0%. Type I to type III endoleak rate was 0%; type II endoleak rate was 4.5%. We registered one paraparesis after the second stage, noted at 4/5, fully recovered after 1 week so that the SCI rate was 4.5% with 0% permanent neurologic deficit. Interstage mean maximum diameter was 68.6 mm (P > .05). After the second step, the mean number of new visible arteries above and below the graft increased by 1.6 and the diameter of the not covered segmental and lumbar arteries by 0.7 6 2 mm (P < .05; Fig 2) .
Conclusions: This is a reproducible adjunct to staged TAAA endovascular repair. The use of a bare branch instead of a branch left completely open has two effects: it gives more stability to the complex, reducing the risk of component migration and disconnection; and furthermore, with a flow modulator-like effect, it does not show an increased risk of aneurysmal growth due to sac hyperpressurization. Left, Preoperative CTA. Middle, CTA control at 6 weeks after the first stage. An initial sac thrombosis is evident; the temporary sac perfusion is sustained by a bare-metal stent connecting the connecting tube port to the connecting tube. Right, CTA control at 1 month after the second step. The bare-metal stent has been relined with a covered stent; a complete sac thrombosis is evident. Left to right, The median sacral artery is slightly visible preoperatively, whereas it gets bigger after the stages, being the reflex of spinal cord preconditioning.
